1. Arslan A, Dilik Z, Özyer M, Oktay N, Yılmaz Ş. Klostridial aşıların potensinin belirlenmesinde toksin nötralizasyon testlerine alternatif olarak ELISA’nın kullanımı, TAGEM Program Değerlendirme Toplantısı, 15-19 Şubat 2016, Antalya.
2. Bonistalli KN (2013). Monoclonal antibody production: A comparision of in vitro and in vivo methods and their use in clostridial vaccine manufacture, MSc, Institute of Veterinary, Animal and Biomedical Sciences, Veterinary Medicine at Massey University, Palmerston North, New Zealand.
3. Borrmann E, Günther H, Köhler H (2001). Effect of Clostridium perfringens epsilon toxin on MDCK cells. FEMS Immunology and Medical Microbiology, 31, 85-92.
4. Borrmann E, Schulze F, Cussler K, Hanel I, Diller R (2006). Development of a cell culture assay fort he quantitative determination of vaccination induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin. Veterinary Microbiology, 114, 41-50.
5. Code of Federal Regulation (CFR) (2019). Clostridium perfringens type D toxoid and bacterin-toxoid, Section 113.112, Title 9:Animal and Animal Products (1-1-21 edition), U.S. Government Publishing Office, p 751-752.